Lipoprotein(a) accelerated the progression of atherosclerosis in patients with end-stage renal disease

BACKGROUND: Increased plasma level of lipoprotein(a) (Lpa) is a risk factor of cardiovascular diseases. This study aimed to explore the role of Lpa in the progression of atherosclerosis in patients with end-stage renal disease (ESRD) and to investigate whether its potential mechanism is mediated by...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Kun Ling, Gong, Tie Kai, Hu, Ze Bo, Zhang, Yang, Wang, Gui Hua, Liu, Liang, Chen, Pei Pei, Lu, Jian, Lu, Chen Chen, Liu, Bi Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090984/
https://www.ncbi.nlm.nih.gov/pubmed/30071823
http://dx.doi.org/10.1186/s12882-018-0986-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090984/
https://www.ncbi.nlm.nih.gov/pubmed/30071823
http://dx.doi.org/10.1186/s12882-018-0986-2

Ejemplares similares